Nuformix (LON:NFX) Trading Down 0.5% – Time to Sell?

Nuformix plc (LON:NFX)’s share price fell 0.5% during trading on Wednesday . The company traded as low as GBX 0.16 and last traded at GBX 0.18. 43,758,137 shares were traded during trading, an increase of 15% from the average session volume of 38,127,719 shares. The stock had previously closed at GBX 0.19.

Nuformix Trading Down 0.5%

The company has a 50 day moving average price of GBX 0.18 and a 200-day moving average price of GBX 0.23. The company has a market cap of £4.80 million, a P/E ratio of -4.68 and a beta of 1.55.

Nuformix (LON:NFX) last issued its quarterly earnings results on Thursday, May 28th. The company reported GBX (0.02) earnings per share (EPS) for the quarter.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.